anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

15,691-15,720 of 319,975

filter-aware
23
This appears to be a page from a formal investigative report or legal document.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
24
The slide is an embedded image within a larger document, likely a report or legal filing.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
25
This page appears to be an excerpt from a legal or investigative report, containing footnotes and narrative text.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
26
This slide is a text-heavy disclosure page from a report, likely a congressional or investigative document.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
27
This appears to be a page from a formal report or legal document, containing narrative text and extensive footnotes.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
28
This appears to be a page from a formal report or legal document, likely an appendix or supporting evidence section.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Evidence & ProofLoop · Cost Of Inaction1 hit
29
This appears to be a page from a formal investigative report or committee document, given the footnote citations.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
30
This appears to be a page from a formal investigative report or legal document, containing narrative text and footnotes.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
31
The slide includes an excerpt from an email sent by McKinsey partners to a client, highlighting their strategy to win business.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
32
This page appears to be from a legal or investigative report, containing numbered footnotes referencing internal documents.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
33
The slide is embedded within a larger document; the red oval is an annotation from the document author, not the original slide.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
34
This appears to be a page from a formal report or legal document, not a standard consulting deck slide.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
35
Page 35 of a larger document, containing extensive footnotes citing legal and journalistic sources.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
36
This is a text-heavy page from a report or legal document, likely an appendix or supporting evidence page.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
37
This is a page from a legal or investigative report, containing footnotes and legal citations.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
38
This is a page from a formal investigative report, likely a Congressional committee report.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
39
This is a page from a formal report or legal document, likely a congressional or investigative committee report.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
40
This appears to be a page from a formal investigative report or legal document.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
41
This appears to be a page from a formal investigative report or legal document, containing footnotes and an email excerpt.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
42
This appears to be a page from a formal investigative report or legal document, indicated by the footnote citations.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
43
This slide appears to be from a report or legal document detailing McKinsey's involvement with Purdue Pharma, specifically focusing on the 'ADF Strategy'.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
44
The slide contains a pull-quote highlighting the core strategy and detailed footnotes citing internal McKinsey documents and external reports.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
45
This slide appears to be a page from a formal report or legal document, containing narrative text and footnotes.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
46
This appears to be a page from a legal or investigative report (indicated by footnotes and redacted text).Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
47
This appears to be a page from a formal investigative report or legal document, given the footnote style and content.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
48
This page contains footnotes 229-236.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
49
This appears to be a page from a formal report or legal document, indicated by the footnote numbering and page number at the bottom.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
50
This appears to be a page from a congressional or investigative report (page 50).Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
51
This page contains footnotes referencing specific internal documents (MCK-HCOR codes) and news articles.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit
52
Page 52 of a report, likely a congressional or investigative document.Opioid Conflicts Majority Staff Report · U.S. House Committee on Oversight and Reform
Consulting deck Strategy consulting Beat · Impact & Next StepsLoop · Cost Of Inaction1 hit